CICigna

Health care · Health Insurance · NYSE

The Cigna Group®, together with its subsidiaries (either individually or collectively referred to as the "Company," "we," "us" or "our"), is a global health company. 10-K, Item 1

Employees: 67,700
Headquarters: Bloomfield, CT
CEO: David Cordani
Next results: around Feb 4, 2027

Compare with peers → Embed

CI and 9 peers, year by year

The 9 Health care companies closest to CI in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.

5 years 10 years Download CSV

Choose the peers

Each company's latest fiscal year
Company	Year	Revenue	Sales growth	Gross margin	Operating margin	Net margin	FCF margin	Return on equity	Debt / equity
CI Cigna	FY2025	$274.9B	+11.2%	-	3.3%	2.2%	-	14.3%	0.74
CAH Cardinal Health	FY2026	$254.2B	+14.2%	3.8%	1.0%	0.7%	1.8%	n/m	n/m
COR Cencora	FY2025	$321.3B	+9.3%	3.6%	0.8%	0.5%	1.0%	103.1%	5.16
CNC Centene Corporation	FY2025	$194.8B	+20.0%	7.3%	−3.9%	−3.4%	2.2%	−33.4%	0.88
ELV Elevance Health	FY2025	$199.1B	+12.5%	-	3.6%	2.8%	1.6%	12.9%	0.73
HUM Humana	FY2025	$129.7B	+10.1%	-	2.1%	0.9%	0.3%	6.7%	0.70
MCK McKesson	FY2026	$403.4B	+12.4%	3.6%	1.5%	1.2%	1.4%	n/m	n/m
CVS CVS Health	FY2025	$402.1B	+7.8%	-	1.2%	0.4%	1.9%	2.4%	0.86
UNH UnitedHealth Group	FY2025	$447.6B	+11.8%	-	4.2%	2.7%	3.6%	12.0%	0.78
JNJ Johnson & Johnson	FY2025	$94.2B	+6.0%	67.9%	-	28.5%	20.9%	32.9%	0.61

Revenuepeer median $254.2B

Sales growthpeer median +11.8%

Gross marginpeer median 3.8%

JNJ 67.9%
CNC 7.3%
CAH 3.8%
MCK 3.6%
COR 3.6%
CI -
ELV -
HUM -
CVS -
UNH -

Operating marginpeer median 1.3%

UNH 4.2%
ELV 3.6%
CI 3.3%
HUM 2.1%
MCK 1.5%
CVS 1.2%
CAH 1.0%
COR 0.8%
CNC −3.9%
JNJ -

Net marginpeer median 0.9%

FCF marginpeer median 1.8%

JNJ 20.9%
UNH 3.6%
CNC 2.2%
CVS 1.9%
CAH 1.8%
ELV 1.6%
MCK 1.4%
COR 1.0%
HUM 0.3%
CI -

Return on equitypeer median 12.0%

Debt / equitypeer median 0.78

COR 5.16
CNC 0.88
CVS 0.86
UNH 0.78
CI 0.74
ELV 0.73
HUM 0.70
JNJ 0.61
CAH n/m
MCK n/m

RevenueSales growthGross marginOperating marginNet marginFree cash flowFCF marginReturn on equityDebt / equityEPS (diluted)

Revenue, FY2016 to FY2025

Revenue as reported in the 10-K.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
CI Dec	$39.8B	$41.8B	$48.6B	$153.6B	$160.4B	$174.1B	$180.5B	$195.3B	$247.1B	$274.9B
CAH Jun	$121.5B	$130.0B	$136.8B	$145.5B	$152.9B	$162.5B	$181.3B	$205.0B	$226.8B	$222.6B
COR Sep	$146.8B	$153.1B	$167.9B	$179.6B	$189.9B	$214.0B	$238.6B	$262.2B	$294.0B	$321.3B
CNC Dec	$40.6B	$48.4B	$60.1B	$74.6B	$111.1B	$126.0B	$144.5B	$154.0B	$163.1B	$194.8B
ELV Dec	$84.9B	$90.0B	$92.1B	$104.2B	$121.9B	$138.6B	$156.6B	$171.3B	$177.0B	$199.1B
HUM Dec	$54.4B	$53.8B	$56.9B	$64.9B	$77.2B	$83.1B	$92.9B	$106.4B	$117.8B	$129.7B
MCK Mar	$190.9B	$198.5B	$208.4B	$214.3B	$231.1B	$238.2B	$264.0B	$276.7B	$309.0B	$359.1B
CVS Dec	$177.5B	$184.8B	$194.6B	$256.8B	$268.7B	$292.1B	$322.5B	$357.8B	$372.8B	$402.1B
UNH Dec	$184.8B	$201.2B	$226.2B	$242.2B	$257.1B	$287.6B	$324.2B	$371.6B	$400.3B	$447.6B
JNJ Dec	$71.9B	$76.5B	$81.6B	$82.1B	-	$78.7B	$80.0B	$85.2B	$88.8B	$94.2B
Peer median	$121.5B	$130.0B	$136.8B	$145.5B	$171.4B	$162.5B	$181.3B	$205.0B	$226.8B	$222.6B

Sales growth, FY2016 to FY2025

Revenue against the fiscal year before.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
CI Dec	-	+4.9%	+16.4%	+216%	+4.5%	+8.5%	+3.7%	+8.2%	+26.6%	+11.2%
CAH Jun	-	+6.9%	+5.3%	+6.4%	+5.1%	+6.2%	+11.6%	+13.0%	+10.7%	−1.9%
COR Sep	+8.0%	+4.3%	+9.7%	+6.9%	+5.7%	+12.7%	+11.5%	+9.9%	+12.1%	+9.3%
CNC Dec	+78.4%	+21.4%	+23.7%	+24.7%	+47.5%	+13.7%	+14.8%	+3.4%	+3.9%	+20.0%
ELV Dec	+7.2%	+6.1%	+2.3%	+13.1%	+16.9%	+13.8%	+13.0%	+9.4%	+3.3%	+12.5%
HUM Dec	+0.2%	−1.1%	+5.8%	+14.0%	+18.9%	+7.7%	+11.8%	+14.5%	+10.7%	+10.1%
MCK Mar	-	+4.0%	+4.9%	+2.9%	+7.8%	+3.1%	+10.8%	+4.8%	+11.7%	+16.2%
CVS Dec	+15.8%	+4.1%	+5.3%	+32.0%	+4.6%	+8.7%	+10.4%	+10.9%	+4.2%	+7.8%
UNH Dec	+17.7%	+8.8%	+12.5%	+7.0%	+6.2%	+11.8%	+12.7%	+14.6%	+7.7%	+11.8%
JNJ Dec	-	+6.3%	+6.7%	+0.6%	-	+13.6%	+1.6%	+6.5%	+4.3%	+6.0%
Peer median	+11.9%	+6.1%	+5.8%	+7.0%	+7.0%	+11.8%	+11.6%	+9.9%	+7.7%	+10.1%

Gross margin, FY2016 to FY2025

Gross profit / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
CI Dec	-	-	-	-	-	-	-	-	-	-
CAH Jun	5.4%	5.0%	5.2%	4.7%	4.5%	4.2%	3.6%	3.4%	3.3%	3.7%
COR Sep	2.9%	3.0%	2.7%	2.9%	2.7%	3.2%	3.5%	3.4%	3.4%	3.6%
CNC Dec	-	-	-	-	-	11.5%	11.7%	11.5%	10.5%	7.3%
ELV Dec	-	-	-	-	-	-	-	-	-	-
HUM Dec	-	-	-	-	-	-	-	-	-	-
MCK Mar	6.0%	5.7%	5.4%	5.5%	5.2%	5.1%	5.0%	4.5%	4.2%	3.7%
CVS Dec	16.3%	15.4%	-	-	-	-	-	-	-	-
UNH Dec	-	-	-	-	-	-	-	-	-	-
JNJ Dec	69.7%	66.7%	66.8%	66.4%	-	70.3%	69.3%	68.8%	69.1%	67.9%
Peer median	6.0%	5.7%	5.3%	5.1%	4.5%	5.1%	5.0%	4.5%	4.2%	3.7%

Operating margin, FY2016 to FY2025

Operating income / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
CI Dec	7.8%	9.4%	8.6%	5.3%	5.1%	4.6%	4.7%	4.4%	3.8%	3.3%
CAH Jun	2.0%	1.6%	0.1%	1.4%	−2.7%	0.3%	−0.3%	0.4%	0.5%	1.0%
COR Sep	1.0%	0.7%	0.9%	0.6%	−2.7%	1.1%	1.0%	0.9%	0.7%	0.8%
CNC Dec	3.1%	2.5%	2.4%	2.4%	2.8%	1.4%	0.9%	1.9%	1.9%	−3.9%
ELV Dec	5.7%	4.6%	5.9%	5.8%	5.2%	5.5%	5.3%	5.0%	4.4%	3.6%
HUM Dec	3.2%	7.9%	5.4%	4.9%	6.5%	3.8%	4.1%	3.8%	2.2%	2.1%
MCK Mar	1.9%	3.6%	0.4%	0.4%	1.1%	−2.1%	0.8%	1.6%	1.3%	1.2%
CVS Dec	5.8%	5.2%	2.1%	4.7%	5.2%	4.6%	2.5%	3.8%	2.3%	1.2%
UNH Dec	7.0%	7.6%	7.7%	8.1%	8.7%	8.3%	8.8%	8.7%	8.1%	4.2%
JNJ Dec	-	-	-	-	-	-	-	-	-	-
Peer median	3.2%	4.1%	2.2%	3.5%	4.0%	2.6%	1.7%	2.8%	2.1%	1.2%

Net margin, FY2016 to FY2025

Net income / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
CI Dec	4.7%	5.4%	5.4%	3.3%	5.3%	3.1%	3.7%	2.6%	1.4%	2.2%
CAH Jun	1.2%	1.0%	0.2%	0.9%	−2.4%	0.4%	−0.5%	0.2%	0.4%	0.7%
COR Sep	1.0%	0.2%	1.0%	0.5%	−1.8%	0.7%	0.7%	0.7%	0.5%	0.5%
CNC Dec	1.4%	1.7%	1.5%	1.8%	1.6%	1.1%	0.8%	1.8%	2.0%	−3.4%
ELV Dec	2.9%	4.3%	4.1%	4.6%	3.8%	4.4%	3.8%	3.5%	3.4%	2.8%
HUM Dec	1.1%	4.6%	3.0%	4.2%	4.4%	3.5%	3.0%	2.3%	1.0%	0.9%
MCK Mar	1.2%	2.6%	0.0%	0.0%	0.4%	−1.9%	0.4%	1.3%	1.0%	0.9%
CVS Dec	3.0%	3.6%	−0.3%	2.6%	2.7%	2.7%	1.3%	2.3%	1.2%	0.4%
UNH Dec	3.8%	5.2%	5.3%	5.7%	6.0%	6.0%	6.2%	6.0%	3.6%	2.7%
JNJ Dec	23.0%	1.7%	18.8%	18.4%	-	26.5%	22.4%	41.3%	15.8%	28.5%
Peer median	1.4%	2.6%	1.5%	2.6%	2.1%	2.7%	1.3%	2.3%	1.2%	0.9%

Free cash flow, FY2016 to FY2025

Cash from operations minus capital spending.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
CI Dec	$3.6B	$3.6B	$3.2B	$8.4B	-	-	-	-	-	-
CAH Jun	$2.5B	$797.0M	$2.4B	$2.4B	$1.6B	$2.0B	$2.8B	$2.4B	$3.3B	$1.9B
COR Sep	$2.7B	$1.0B	$1.1B	$2.0B	$1.8B	$2.2B	$2.2B	$3.5B	$3.0B	$3.2B
CNC Dec	$1.5B	$1.1B	$559.0M	$753.0M	$4.6B	$3.3B	$5.3B	$7.3B	−$490.0M	$4.3B
ELV Dec	$2.7B	$3.4B	$2.6B	$5.0B	$9.7B	$7.3B	$7.2B	$6.8B	$4.6B	$3.2B
HUM Dec	$1.4B	$3.5B	$1.6B	$4.5B	$4.7B	$920.0M	$3.5B	$3.0B	$2.4B	$375.0M
MCK Mar	$3.2B	$4.3B	$3.9B	$3.6B	$4.0B	$4.1B	$4.0B	$4.8B	$3.9B	$5.5B
CVS Dec	$7.9B	$6.1B	$6.8B	$10.4B	$13.4B	$15.7B	$13.4B	$10.4B	$6.3B	$7.8B
UNH Dec	$8.1B	$11.6B	$13.7B	$16.4B	$20.1B	$19.9B	$23.4B	$25.7B	$20.7B	$16.1B
JNJ Dec	$15.5B	$17.8B	$18.5B	$19.9B	-	$19.8B	$17.2B	$18.2B	$19.8B	$19.7B
Peer median	$2.7B	$3.5B	$2.6B	$4.5B	$4.7B	$4.1B	$5.3B	$6.8B	$3.9B	$4.3B

FCF margin, FY2016 to FY2025

Free cash flow / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
CI Dec	8.9%	8.6%	6.7%	5.5%	-	-	-	-	-	-
CAH Jun	2.1%	0.6%	1.7%	1.6%	1.0%	1.2%	1.5%	1.2%	1.4%	0.8%
COR Sep	1.8%	0.7%	0.6%	1.1%	1.0%	1.0%	0.9%	1.3%	1.0%	1.0%
CNC Dec	3.8%	2.2%	0.9%	1.0%	4.2%	2.6%	3.6%	4.7%	−0.3%	2.2%
ELV Dec	3.2%	3.8%	2.8%	4.8%	7.9%	5.2%	4.6%	3.9%	2.6%	1.6%
HUM Dec	2.6%	6.6%	2.7%	7.0%	6.1%	1.1%	3.7%	2.8%	2.0%	0.3%
MCK Mar	1.7%	2.2%	1.9%	1.7%	1.7%	1.7%	1.5%	1.7%	1.3%	1.5%
CVS Dec	4.5%	3.3%	3.5%	4.0%	5.0%	5.4%	4.2%	2.9%	1.7%	1.9%
UNH Dec	4.4%	5.8%	6.0%	6.8%	7.8%	6.9%	7.2%	6.9%	5.2%	3.6%
JNJ Dec	21.6%	23.3%	22.7%	24.3%	-	25.1%	21.5%	21.4%	22.3%	20.9%
Peer median	3.2%	3.3%	2.7%	4.0%	4.6%	2.6%	3.7%	2.9%	1.7%	1.6%

Return on equity, FY2016 to FY2025

Net income / shareholders' equity at the year end.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
CI Dec	13.6%	16.3%	6.4%	11.3%	16.8%	11.4%	15.0%	11.2%	8.4%	14.3%
CAH Jun	21.8%	18.9%	4.2%	21.5%	n/m	34.1%	n/m	n/m	n/m	n/m
COR Sep	67.1%	17.7%	56.5%	29.7%	n/m	n/m	n/m	n/m	n/m	103.1%
CNC Dec	9.5%	12.1%	8.2%	10.5%	7.0%	5.0%	5.0%	10.5%	12.5%	−33.4%
ELV Dec	9.8%	14.5%	13.1%	15.2%	13.8%	17.1%	16.3%	15.2%	14.5%	12.9%
HUM Dec	5.7%	24.9%	16.6%	22.5%	24.5%	18.2%	18.3%	15.3%	7.4%	6.7%
MCK Mar	25.3%	45.7%	0.7%	0.4%	17.7%	n/m	n/m	n/m	n/m	n/m
CVS Dec	14.4%	17.6%	−1.0%	10.4%	10.3%	10.7%	6.0%	10.9%	6.1%	2.4%
UNH Dec	18.4%	21.2%	22.1%	22.9%	22.5%	23.0%	24.7%	23.7%	14.7%	12.0%
JNJ Dec	23.5%	2.2%	25.6%	25.4%	-	28.2%	23.4%	51.1%	19.7%	32.9%
Peer median	18.4%	17.7%	13.1%	21.5%	15.7%	18.2%	17.3%	15.3%	13.5%	12.0%

Debt / equity, FY2016 to FY2025

Total debt / shareholders' equity at the year end.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
CI Dec	-	0.40	1.00	0.72	0.61	0.70	0.63	0.64	0.73	0.74
CAH Jun	0.85	1.65	1.49	1.27	3.79	3.48	n/m	n/m	n/m	n/m
COR Sep	1.97	1.67	0.11	1.49	n/m	n/m	n/m	10.40	7.69	5.16
CNC Dec	0.81	0.70	0.63	1.10	0.65	0.71	0.76	0.70	0.71	0.88
ELV Dec	0.63	0.75	0.66	0.62	0.61	0.64	0.67	0.64	0.76	0.73
HUM Dec	0.38	0.50	0.60	0.47	0.49	0.78	0.73	0.72	0.72	0.70
MCK Mar	0.91	0.77	0.80	0.94	1.45	n/m	n/m	n/m	n/m	n/m
CVS Dec	0.75	0.75	1.27	1.07	0.93	0.75	0.73	0.81	0.88	0.86
UNH Dec	0.86	0.64	0.67	0.67	0.64	0.61	0.71	0.66	0.78	0.78
JNJ Dec	0.41	0.60	0.55	0.47	-	0.48	0.54	0.45	0.54	0.61
Peer median	0.81	0.75	0.66	0.94	0.65	0.71	0.72	0.70	0.76	0.78

EPS (diluted), FY2016 to FY2025

Diluted earnings per share, on today's share count after splits.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
CI Dec	$7.19	$8.77	$10.54	$13.44	$22.96	$15.75	$21.41	$17.39	$12.12	$22.18
CAH Jun	$4.32	$4.03	$0.81	$4.53	−$12.61	$2.08	−$3.37	$1.26	$3.45	$6.45
COR Sep	$6.32	$1.64	$7.53	$4.04	−$16.65	$7.39	$8.04	$8.53	$7.53	$7.96
CNC Dec	$1.71	$2.34	$2.26	$3.14	$3.12	$2.28	$2.07	$4.95	$6.31	−$13.53
ELV Dec	$9.21	$14.35	$14.19	$18.47	$17.98	$24.95	$24.28	$25.22	$25.68	$25.21
HUM Dec	$4.07	$16.81	$12.16	$20.10	$25.31	$22.67	$22.08	$20.00	$9.98	$9.84
MCK Mar	$9.70	$22.73	$0.32	$0.17	$4.95	−$28.26	$7.23	$25.03	$22.39	$25.72
CVS Dec	$4.90	$6.44	−$0.57	$5.08	$5.46	$6.02	$3.26	$6.47	$3.66	$1.39
UNH Dec	$7.25	$10.72	$12.19	$14.33	$16.03	$18.08	$21.18	$23.86	$15.51	$13.23
JNJ Dec	$5.93	$0.47	$5.61	$5.63	-	$7.81	$6.73	$13.72	$5.79	$11.03
Peer median	$5.93	$6.44	$5.61	$5.08	$5.21	$7.39	$7.23	$13.72	$7.53	$9.84

Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out CI and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more →

Work on CI in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/CI/export.csv") into a cell.